BULLFROG AI HOLDINGS INC. - COMMON STOCK

BullFrog AI to Participate at the H.C. Wainwright 26th Annual Global Investment Conference

26 أغسطس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI and Lieber Institute for Brain Development Reveal New Insights into Bipolar Disorder Pathways and Potential Drug Targets

25 يوليو 2024 07:30:00 بحسب Nasdaq GlobeNewswire

Join BullFrog AI’s Exclusive Live Investor Webinar and Q&A Session on June 12

29 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI and Lieber Institute for Brain Development Collaboration Identifies Novel Drug Targets for Neuropsychiatric Disorders

16 مايو 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo

09 أبريل 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute

08 مارس 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer

26 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Announces Underwriter’s Decision to Exercise Over-Allotment Option to Purchase 218,382 Shares of the Company’s Common Stock

21 فبراير 2024 12:01:05 بحسب Nasdaq GlobeNewswire

BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip

09 فبراير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Announces Closing of $5.7 Million Public Offering

05 فبراير 2024 10:00:57 بحسب Nasdaq GlobeNewswire

Bullfrog AI Announces Pricing of $5.7 Million Public Offering

01 فبراير 2024 09:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala

26 يناير 2024 07:30:00 بحسب Nasdaq GlobeNewswire

BullFrog AI’s Collaboration with Lieber Institute for Brain Development Yields Potentially Groundbreaking Biological Stratification of Brain Expression Data

17 يناير 2024 07:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer

16 يناير 2024 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI to Present at Webull LIVE! Healthcare Webinar on January 17

11 يناير 2024 16:05:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Issues Letter to Shareholders

29 ديسمبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Launches Preclinical Study to Investigate BF-114’s Potential in Battling Obesity

06 ديسمبر 2023 07:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI to Present at Benzinga All Access Event on October 20

18 أكتوبر 2023 09:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform

05 أكتوبر 2023 08:00:00 بحسب Nasdaq GlobeNewswire

BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma

26 سبتمبر 2023 08:00:01 بحسب Nasdaq GlobeNewswire